- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05586308
Incentive-based and Media Literacy Informed Approaches to Improve Vaping Cessation
October 7, 2023 updated by: University of Nebraska
Pilot Study of Incentive-based and Media Literacy-informed Approaches to Improve Vaping Cessation Among Young Adults
This study aims to evaluate the feasibility and compare the preliminary effect of vaping cessation program consisting of media literacy education and real-time text messaging support and leverage insights from behavioral economics to enhance social and financial incentives to improve program engagement, and eventually abstinence.
Our hypotheses are that 1) the Combined arm is associated with improved vaping abstinence to the Media literacy and Financial incentive arms; and 2) the financial incentive-related arms (either Combined or Financial incentive) enhance engagement compared to the non-incentive related arms.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective of this pilot study is to evaluate the feasibility and compare the potential effect of different vaping cessation intervention components in addition to evidence-based text-messaging support, including 1) media literacy interactive e-learning lessons, 2) financial incentives, and 3) combined (media literacy + financial incentive) on vaping abstinence among current young adult vapers over a three-month timeframe with the following three specific aims: Aim 1.
To assess the feasibility of a multi-component vaping cessation program; Aim 2 To evaluate the preliminary effect of a multicomponent vaping cessation program; and exploratory Aim 3. To Examine the cost-consequence of a multicomponent vaping cessation program.
Eligible participants are young adults aged 19-29 and are current vapers (i.e., has vaped in the previous 30 days).We will employ a 4-arm, feasibility randomized trial design to determine the preliminary effect of different vaping intervention components on vaping abstinence over a 3-month timeframe, consisting of a 1-month quitting preparation phase and 2-month abstinence phase.
Eligible participants (n=80) will be randomized (in a 1:1:1:1 ratio), using a computer-generated algorithm, to to one of four vaping cessation interventions: 1) Active control: text-messaging support, 2) Media literacy: media literacy + text-messaging support, 3) Financial incentive: financial incentive + text-messaging support, and 4) Combined: media literacy e-learning lessons + financial incentive + text-messaging support, at the baseline visit.
Regardless of intervention arms, all enrolled participants will receive receive an evidence-base text-messaging support program for quitting vaping (This is Quitting).
Participants will be followed through a 3-month study period including a 1-month quitting preparation phase and a 2-month abstinence phase.
All participants will be asked to provide the 5 saliva cotinine samples- at baseline and end-of-study visits and 3 at video calls (remote submissions).
Participants who assigned to the financial incentive Combined groups will be provided monetary rewards for submitting saliva cotinine samples during the abstinence period.
To examine the feasibility of biomarker testing for toxic exposures, for a subsample of 20 participants, a panel of biomarkers of toxic exposures will be measured at baseline and at the end of study.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tzeyu Michaud, PhD
- Phone Number: 402-836-9195
- Email: tzeyu.michaud@unmc.edu
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198
- Recruiting
- Unversity of Nebraska Medical Center
-
Contact:
- Tzeyu Michaud, PhD
- Phone Number: 402-836-9195
- Email: tzeyu.michaud@unmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 29 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 19-29
- Report vaping in the previous 30 days
- Have access to internet/video chat/SMS text message
- Are interested in quitting vaping in the next 30 days
Exclusion Criteria:
- Must meet all the inclusion criteria
- Self-report as currently pregnant or planning to become pregnant in the next 3 months
- Already involved in vaping cession programs (either behavioral or medical intervention)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Active control
Participants in this arm will receive an evidence-based text-messaging support.
|
Text-messaging quitting support program (i.e., This is Quitting) is an evidence-based, free mobile program from Truth Initiative designed to help young people quit vaping.
The program is fully automated and interactive.
To establish or reinforce perceived social norms and social support around quitting, a majority of messages come from other users who have submitted them to the program.
|
Active Comparator: Media literacy
Participants will receive media literacy e-learning lessons and an evidence-based text-messaging support.
|
Text-messaging quitting support program (i.e., This is Quitting) is an evidence-based, free mobile program from Truth Initiative designed to help young people quit vaping.
The program is fully automated and interactive.
To establish or reinforce perceived social norms and social support around quitting, a majority of messages come from other users who have submitted them to the program.
Media literacy e-learning lessons cover topics regarding what e-cigarettes are and how they work, how nicotine and nicotine addiction affects the brain and behavior, how to prepare to quit vaping, developing a quit plan and how to deal with cravings and relapse.
The program focuses on changing knowledge, attitudes and beliefs related to e-cigarette use, as well as emphasizing vaping related media literacy.
|
Active Comparator: Financial incentive
Participants will receive financial incentive intervention and an evidence-based text-messaging support.
|
Text-messaging quitting support program (i.e., This is Quitting) is an evidence-based, free mobile program from Truth Initiative designed to help young people quit vaping.
The program is fully automated and interactive.
To establish or reinforce perceived social norms and social support around quitting, a majority of messages come from other users who have submitted them to the program.
|
Experimental: Combined
Participants will receive media literacy e-learning lessons, financial incentive, and an evidence-based text-messaging support program.
|
Text-messaging quitting support program (i.e., This is Quitting) is an evidence-based, free mobile program from Truth Initiative designed to help young people quit vaping.
The program is fully automated and interactive.
To establish or reinforce perceived social norms and social support around quitting, a majority of messages come from other users who have submitted them to the program.
Media literacy e-learning lessons cover topics regarding what e-cigarettes are and how they work, how nicotine and nicotine addiction affects the brain and behavior, how to prepare to quit vaping, developing a quit plan and how to deal with cravings and relapse.
The program focuses on changing knowledge, attitudes and beliefs related to e-cigarette use, as well as emphasizing vaping related media literacy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biochemically verified vaping abstinence
Time Frame: 3 months
|
Biochemically verified vaping abstinence (negative results- < 30 ng/mL) will be measured by saliva cotinine samples at end of study (Week 12).
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Engagement
Time Frame: 3 months
|
Engagement will be assessed by: a) proportions of media literacy e-learning lessons completed at the end of the quitting preparation phase (Week 4), and b) proportions of participants who submitted the remote saliva cotinine sample at each scheduled time-point at end of study (Week 12);
|
3 months
|
Nicotine dependence index
Time Frame: 3 months
|
Nicotine dependence index will be measured by the Penn State E-cigarette Dependence (PSECD) index at baseline and end-of-study
|
3 months
|
Media literacy
Time Frame: 3 months
|
Media literacy will be measured by the vaping media literacy scale at baseline and end of study visits.
|
3 months
|
Self-reported vaping abstinence
Time Frame: 3 months
|
Self-reported vaping abstinence will be assessed by the question "In the past 30 days, did you vape at all, even a puff of someone else?" at the end-of-study visit.
|
3 months
|
Biomarkers of toxic exposures
Time Frame: 3 months
|
Twenty participants will provide the urine sample at the baseline and end-of-study visits (2 months after the target quit date) at the study clinic.
The biomarker classes may include: 1) cotinine and hydroxycotinine, and 2) creatinine.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tzeyu Michaud, PhD, University of Nebraska
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2023
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
October 14, 2022
First Submitted That Met QC Criteria
October 14, 2022
First Posted (Actual)
October 19, 2022
Study Record Updates
Last Update Posted (Actual)
October 11, 2023
Last Update Submitted That Met QC Criteria
October 7, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 0596-22-EP
- U54GM115458 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data obtained through this study may be provided to qualified researchers with academic interest in vaping cessation program targeting youth/young adults.
Data shared will be coded, with no PHI included.
Approval of the request and execution of all applicable agreements (i.e. a data transfer/use agreement) are prerequisites to the sharing of data with the requesting party.
IPD Sharing Time Frame
Data requests can be submitted starting 12 months after article publication and the data will be made accessible for up to 24 months.
Extensions will be considered on a case-by-case basis
IPD Sharing Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing/USE Agreement.
IPD Sharing Supporting Information Type
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Engagement, Patient
-
Cedars-Sinai Medical CenterTerminated
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
Inonu UniversityCompleted
-
The University of Texas at ArlingtonAgency for Healthcare Research and Quality (AHRQ)RecruitingPatient Engagement | Patient Empowerment | Patient ActivationUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; TalkspaceRecruiting
-
Medical College of WisconsinCompletedCommunication | Patient EngagementUnited States
-
The Cleveland ClinicRecruitingPatient EngagementUnited States
-
University of North Carolina, Chapel HillCompleted
-
Palo Alto Medical FoundationUniversity of Rochester; Dartmouth College; Gordon and Betty Moore Foundation; ... and other collaboratorsCompletedPatient Engagement | Physician's Role | Physician-Patient Relationship
-
NYU Langone HealthCompleted
Clinical Trials on Text-massaging suport
-
Government College of Dentistry, IndoreUnknown
-
Government College of Dentistry, IndoreCompleted
-
Friedrich-Alexander-Universität Erlangen-NürnbergPhilipps University Marburg Medical CenterCompleted
-
University of PittsburghUniversity of Michigan; Allegheny Singer Research Institute (also known as...Completed
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
Children's Hospitals and Clinics of MinnesotaHealthPartners InstituteUnknownAsthmaUnited States
-
University of RochesterAmerican College of Chest PhysiciansRecruiting
-
Duke UniversityCompleted
-
Taipei Medical UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterHackensack Meridian Health; The City College of New YorkActive, not recruitingHPV VaccinationUnited States